Articles of Interest to People with ALS

Amyotrophic Lateral Sclerosis (ALS):
The Diagnosis and Treatment of this Debilitating Disease
This article by Dr Andrew Eisen, Vancouver, BC, was originally published in Geriatrics and Aging
Originally published in: Volume 3, Number 9, November 2000
In 1869, French neurologist Jean-Martin Charcot first described a rapidly progressive, fatal neuromuscular disease. This disease, amyotrophic lateral sclerosis, or Lou-Gehrig's disease, is a neurodegenerative disorder that affects the patient's motor neurons; typically the patient is paralyzed or deceased within 2 to 5 years of the initial diagnosis. Currently, approximately 3000 Canadians suffer from this tragic disease.
>> Read Full Article

ALS/MND: The Dangers of Unproven "Therapies"
All of those involved in ALS/MND, be they health professionals, care-givers and, most of all, patients with ALS/MND, are only too aware of the grave significance and implications of the disease. This results in a variable degree of desperation which makes all three vulnerable to try anything, for what is there to lose? There are several categories of drug therapy.
>> Read Full article

Dr Heather Durham, a researcher in Montreal who is funded by our Neuroluscular Research Partnership, has kindly given us permission to post her presentation ALS RESEARCH - YESTERDAY, TODAY & TOMORROW. 
(It is a Power point presentation and requires Microsoft PowerPoint to view.)